William van Dongen

William van Dongen has extensive experience in the pharmaceutical and bioanalytical industry. William is currently serving as the Director of Research & Development at Pharming Group N.V., where they are responsible for overseeing the development and manufacturing of commercial pharmaceuticals. Prior to this, William held various roles such as the Director of Manufacturing Science and Technology at Pharming Group N.V., Head of Research & Development at Anabiotec, and Director of Analytical R&D at Teva Pharmaceuticals. William has also worked at ProQR Therapeutics NV, TNO Pharma & TNO Triskelion, and Synthon BV, where they gained expertise in product characterization, bioanalytics, and analytical method development. Throughout their career, William has demonstrated strong leadership skills and a commitment to scientific excellence.

William van Dongen has a Ph.D. in Bioanalytical Chemistry from Utrecht University and a Master's Degree in Analytical Chemistry from Vrije Universiteit Amsterdam (VU Amsterdam).